Genetic variation enhances cancer drug sensitivity
By exploiting the genetic variation in cancer cells, an already approved cancer drug demonstrated enhanced effects against cancer cells in specific patient groups, according to a new study. The findings suggest a potential for more individually tailored and more effective cancer therapies.
